Human Antibody Therapeutics for Viral Disease

The articles in this volume have been selected to demonstrate the progress in the development of human antibody therapeutics for viral disease. Keck et al. review the nature of the immune response to the Hepatitis C virus (HCV) and the details of viral neutralization by antibodies, providing a conce...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Dessain, Scott K. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2008.
Σειρά:Current Topics in Microbiology and Immunology, 317
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03766nam a22004335i 4500
001 978-3-540-72146-8
003 DE-He213
005 20151204191611.0
007 cr nn 008mamaa
008 100301s2008 gw | s |||| 0|eng d
020 |a 9783540721468  |9 978-3-540-72146-8 
024 7 |a 10.1007/978-3-540-72146-8  |2 doi 
040 |d GrThAP 
050 4 |a QR355-502 
072 7 |a MMFM  |2 bicssc 
072 7 |a MED052000  |2 bisacsh 
082 0 4 |a 616.9101  |2 23 
245 1 0 |a Human Antibody Therapeutics for Viral Disease  |h [electronic resource] /  |c edited by Scott K. Dessain. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2008. 
300 |a XII, 190 p. 18 illus., 7 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Topics in Microbiology and Immunology,  |x 0070-217X ;  |v 317 
505 0 |a Therapeutic Control of Hepatitis C Virus: The Role of Neutralizing Monoclonal Antibodies -- Antibodies for HIV Treatment and Prevention: Window of Opportunity? -- Human Monoclonal Antibody and Vaccine Approaches to Prevent Human Rabies -- Immunoprophylaxis of RSV Infection: Advancing from RSV-IGIV to Palivizumab and Motavizumab -- The Molecular Basis of Antibody Protection Against West Nile Virus -- Exploring the Native Human Antibody Repertoire to Create Antiviral Therapeutics. 
520 |a The articles in this volume have been selected to demonstrate the progress in the development of human antibody therapeutics for viral disease. Keck et al. review the nature of the immune response to the Hepatitis C virus (HCV) and the details of viral neutralization by antibodies, providing a conceptual model for the clinical use of HCV-specific antibodies. Huber et al. summarize the initial clinical experiences with antibody therapeutics for Human Immunodeficiency Virus that can be targeted to either the HIV virion or to host cell proteins. A discussion of the breadth immune strategies that is required to control human rabies is provided by Nagarajan et al., with a particular focus on India and other countries in which rabies is endemic. The development of pavilizumab for RSV prophylaxis is reviewed in Wu et al., in addition to results of antibody optimization studies that provide surprising insights and have broad general implications for anti-viral antibody engineering. Melhop and Diamond explicate the biology of West Nile Virus as a general model for flaviviruses, while using their cloned antibodies as a springboard to consider the mechanisms of WNV neutralization. The volume concludes with a description of methods to clone human antibodies in their native configurations, which access a class of antibodies that differ from those obtained by recombinant DNA or transgenic mouse methods. The articles in this volume are definitive and comprehensive reviews written by experts who have sought to define the principles of viral neutralization by human antibodies. They explore and anticipate the obstacles and opportunities that will be encountered as the power of human antibodies is harnessed to address the vast, un-met need for effective anti-viral therapeutics. 
650 0 |a Medicine. 
650 0 |a Virology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Virology. 
700 1 |a Dessain, Scott K.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540721444 
830 0 |a Current Topics in Microbiology and Immunology,  |x 0070-217X ;  |v 317 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-72146-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)